1st Quarter - Report

COVE STRATEGIES for RETROPHIN, INC.

Period 1st Quarter 2019 Filed Apr 22, 2019 Signed by Matthew Schlapp

Official filing
Firm
COVE STRATEGIES
Client
RETROPHIN, INC.
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General issues related to rare disease and patient care

LobbyistCovered position, as disclosed
ANGELA FLOOD —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Pharmacy PHA

General issues related to the CREATES Act, the Orphan Drug Act, and drug pricing

LobbyistCovered position, as disclosed
ANGELA FLOOD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.